| Akm Abuhiya, MD | |
|
500 Mcmillen St, Fort Atkinson, WI 53538-1233 | |
| (920) 563-5571 | |
| Not Available |
| Full Name | Akm Abuhiya |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 500 Mcmillen St, Fort Atkinson, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164043097 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 82334-20 (Wisconsin) | Primary |
| Entity Name | Fort Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417993361 PECOS PAC ID: 0840189718 Enrollment ID: O20040319001411 |
News Archive
Researchers at the McKusick-Nathans Institute of Genetic Medicine (IGM) at Johns Hopkins will join other national and international scientists in the 1000 Genomes Project, an ambitious effort that will involve sequencing the genomes of numerous people from around the world to create the most detailed and medically useful picture to date of human genetic variation.
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS) today announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to Restanza(TM) (cethromycin), its novel, once daily oral antibiotic, for the prophylactic treatment of plague and tularemia. Both tularemia and plague are classified by the Centers for Disease Control as Category A Bioterrorism Agents, which is the highest priority classification.
A discovery by scientists at Dana-Farber Cancer Institute and University of Texas Southwestern Medical Center presents drug developers with an entirely new tack in targeting one of the most-wanted molecular culprits in cancer.
Researchers at Sam Houston State University and the University of Texas at Austin will team up with representatives from the criminal justice system in Houston to establish protocols to determine when sexual assault kits need to be tested by crime labs.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Akm Abuhiya, MD 500 Mcmillen St, Fort Atkinson, WI 53538-1233 Ph: (920) 563-5571 | Akm Abuhiya, MD 500 Mcmillen St, Fort Atkinson, WI 53538-1233 Ph: (920) 563-5571 |
News Archive
Researchers at the McKusick-Nathans Institute of Genetic Medicine (IGM) at Johns Hopkins will join other national and international scientists in the 1000 Genomes Project, an ambitious effort that will involve sequencing the genomes of numerous people from around the world to create the most detailed and medically useful picture to date of human genetic variation.
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS) today announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to Restanza(TM) (cethromycin), its novel, once daily oral antibiotic, for the prophylactic treatment of plague and tularemia. Both tularemia and plague are classified by the Centers for Disease Control as Category A Bioterrorism Agents, which is the highest priority classification.
A discovery by scientists at Dana-Farber Cancer Institute and University of Texas Southwestern Medical Center presents drug developers with an entirely new tack in targeting one of the most-wanted molecular culprits in cancer.
Researchers at Sam Houston State University and the University of Texas at Austin will team up with representatives from the criminal justice system in Houston to establish protocols to determine when sexual assault kits need to be tested by crime labs.
› Verified 7 days ago
Catherine L Sweeney, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 500 Mcmillen St, Fort Atkinson, WI 53538 Phone: 920-563-5571 Fax: 920-563-7705 |